Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8151 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8112 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8112 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8028 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7974 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7958 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7887 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7842 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7714 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7651 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7651 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7639 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7625 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7556 |
Intermediate Similarity |
NPD228 |
Approved |
0.7531 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.753 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.753 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7515 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1357 |
Approved |
0.75 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.741 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7362 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7329 |
Intermediate Similarity |
NPD37 |
Approved |
0.7319 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7308 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7301 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7301 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7301 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7284 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7284 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7267 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7251 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7246 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7226 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7211 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7203 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7203 |
Intermediate Similarity |
NPD5846 |
Approved |
0.72 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7197 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7183 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7178 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7134 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7133 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7124 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7124 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7123 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7122 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7117 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7086 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.708 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7078 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7078 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7073 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7067 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7059 |
Intermediate Similarity |
NPD968 |
Approved |
0.7055 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7052 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7052 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7047 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7029 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7029 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7019 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7007 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.6993 |
Remote Similarity |
NPD3657 |
Discovery |
0.6982 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6977 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6977 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6972 |
Remote Similarity |
NPD6671 |
Approved |
0.6971 |
Remote Similarity |
NPD8312 |
Approved |
0.6971 |
Remote Similarity |
NPD8313 |
Approved |
0.697 |
Remote Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD1511 |
Approved |
0.6928 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD2122 |
Discontinued |
0.6899 |
Remote Similarity |
NPD4237 |
Approved |
0.6899 |
Remote Similarity |
NPD4162 |
Approved |
0.6899 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6894 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6894 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD3882 |
Suspended |
0.6883 |
Remote Similarity |
NPD5735 |
Approved |
0.6882 |
Remote Similarity |
NPD7680 |
Approved |
0.6879 |
Remote Similarity |
NPD5535 |
Approved |
0.6875 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD3687 |
Approved |
0.6871 |
Remote Similarity |
NPD3686 |
Approved |
0.6867 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6867 |
Remote Similarity |
NPD7089 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.6859 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6859 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6859 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6855 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6855 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6852 |
Remote Similarity |
NPD1512 |
Approved |
0.6846 |
Remote Similarity |
NPD8651 |
Approved |
0.6845 |
Remote Similarity |
NPD5604 |
Discontinued |
0.6842 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6832 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6832 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6829 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.6826 |
Remote Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6824 |
Remote Similarity |
NPD2235 |
Phase 2 |
0.6824 |
Remote Similarity |
NPD2231 |
Phase 2 |
0.6821 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6813 |
Remote Similarity |
NPD2677 |
Approved |
0.6792 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.679 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6788 |
Remote Similarity |
NPD4675 |
Approved |
0.6788 |
Remote Similarity |
NPD4678 |
Approved |
0.6788 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6779 |
Remote Similarity |
NPD4749 |
Approved |
0.6774 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6772 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6766 |
Remote Similarity |
NPD5772 |
Approved |
0.6766 |
Remote Similarity |
NPD5773 |
Approved |
0.6763 |
Remote Similarity |
NPD290 |
Approved |
0.6757 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6753 |
Remote Similarity |
NPD2674 |
Phase 3 |
0.675 |
Remote Similarity |
NPD4535 |
Phase 3 |
0.6748 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.6746 |
Remote Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.6735 |
Remote Similarity |
NPD5126 |
Approved |
0.6735 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.673 |
Remote Similarity |
NPD7037 |
Approved |
0.6728 |
Remote Similarity |
NPD1774 |
Approved |
0.6723 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6722 |
Remote Similarity |
NPD7906 |
Approved |
0.671 |
Remote Similarity |
NPD4140 |
Approved |
0.6709 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6708 |
Remote Similarity |
NPD5241 |
Discontinued |
0.6705 |
Remote Similarity |
NPD2489 |
Approved |
0.6705 |
Remote Similarity |
NPD27 |
Approved |
0.6689 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6688 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6688 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6688 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6687 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6687 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.6686 |
Remote Similarity |
NPD3051 |
Approved |
0.6686 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6685 |
Remote Similarity |
NPD4578 |
Approved |
0.6685 |
Remote Similarity |
NPD4577 |
Approved |
0.6667 |
Remote Similarity |
NPD4663 |
Approved |
0.6667 |
Remote Similarity |
NPD7039 |
Approved |
0.6667 |
Remote Similarity |
NPD5327 |
Phase 3 |
0.6667 |
Remote Similarity |
NPD7038 |
Approved |
0.6667 |
Remote Similarity |
NPD3685 |
Discontinued |
0.6667 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD5762 |
Approved |
0.6667 |
Remote Similarity |
NPD5451 |
Approved |
0.6667 |
Remote Similarity |
NPD5763 |
Approved |
0.6667 |
Remote Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD6800 |
Clinical (unspecified phase) |
0.6648 |
Remote Similarity |
NPD8054 |
Approved |
0.6648 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6648 |
Remote Similarity |
NPD8053 |
Approved |
0.6647 |
Remote Similarity |
NPD2970 |
Approved |
0.6647 |
Remote Similarity |
NPD2969 |
Approved |
0.6647 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6646 |
Remote Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.6644 |
Remote Similarity |
NPD1535 |
Discovery |
0.6642 |
Remote Similarity |
NPD291 |
Approved |
0.663 |
Remote Similarity |
NPD6841 |
Approved |
0.663
|
Remote Similarity |
NPD6843 |
Phase 3 |